ORCID as entered in ROS

Select Publications
2011, 'The role of type II spiral ganglion neurons in the regulation of hearing sensitivity via the medial olivocochlear efferent pathway', in PROCEEDINGS OF THE AUSTRALIAN PHYSIOLOGICAL SOCIETY Volume 42, Perth, presented at Australian Physiological Society, Perth, 04 December 2011 - 07 December 2011, http://aups.org.au/Proceedings/42/
,2011, 'Contribution of cochlear P2X2 receptors (ATP-gated ion channels) to hearing adaptation', in Molecular Biology of Hearing and Deafness conference, Cambridge, UK, presented at Molecular Biology of Hearing and Deafness conference, Cambridge, UK
,2010, Drugs that can reverse deafness: Post-exposure activation of A1 adenosine receptors mitigates noise-induced cochlear injury, British Academy of Audiology, UK, vol. 19, pp. 22-23., http://www.esrc.ac.uk/my-esrc/c96c2b90-af54-45cb-9c1f-b7ae7c92d3be
,2024, Electroporation apparatus for providing agents to the cochlea, Europe; France; Germany; UK, Patent No. Europe/France/UK - 3488837; Germany - '602010069586.7
,2024, Method and system for controlling molecular electrotransfer, Patent No. Japan - 7489116;
,2023, Noise-induced hearing loss susceptibility test method and test apparatus, United States, Patent No. 11850044
,2023, Electroporation system for controlled localized therapeutics delivery, New Zealand, Patent No. 737871
,2021, Electroporation system for controlled localized therapeutics delivery, Patent No. Australian 2021 pat no.2016282210; China pat no.ZL201680037448.8; India pat no. 365630, Japan pat no. 6987642
,2021, Method and apparatus for close-field electroporation, Germany, Patent No. 602014077033.9
,2019, Agent provided to the cochlea and cochlear implant, Patent No. 2453856
,2017, Method of providing agents to the cochlea, United States, Patent No. US20140194807; US20170173323; 11026842 (US 2021), http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=US-9533138-B2
,2021, Association of cochlear outer hair cell - type II spiral ganglion afferents with protection from noise-induced hearing loss, http://dx.doi.org/10.1101/2021.11.06.467554
,2018, Conditional Upregulation of KCC2 selectively enhances neuronal inhibition during seizures, http://dx.doi.org/10.1101/253831
,